Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Laakmann E, Witzel I, Fasching PA, Rezai M, Schem C, Solbach C, Tesch H, Klare P, Schneeweiss A, Salat C, Zahm DM, Blohmer JU, Ingold-Heppner B, Huober J, Hanusch C, Jackisch C, Reinisch M, Untch M, von Minckwitz G, Nekljudova V, Müller V, Loibl S.
Laakmann E, et al. Among authors: solbach c.
Breast Cancer Res. 2019 May 10;21(1):60. doi: 10.1186/s13058-019-1144-x.
Breast Cancer Res. 2019.
PMID: 31077239
Free PMC article.